GUJINJECPharmaceuticals
Gujarat Inject Kerala Ltd — Cash Flow Statement
₹74.50
+0.68%
Gujarat Inject Kerala Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -3.52 Cr | -5.83 Cr | 0.05 Cr | -9904.00 | — |
| Issuance Of Capital Stock | 0.45 Cr | 9.30 Cr | 0.00 | — | — |
| End Cash Position | 0.03 Cr | 2.92 Cr | 0.06 Cr | 75095.00 | — |
| Beginning Cash Position | 2.92 Cr | 0.06 Cr | 75095.00 | 84999.00 | — |
| Changes In Cash | -2.89 Cr | 2.86 Cr | 0.05 Cr | -9904.00 | — |
| Financing Cash Flow | 0.63 Cr | 8.69 Cr | 0.00 | 0.00 | — |
| Net Other Financing Charges | 0.18 Cr | — | — | — | — |
| Interest Paid Cff | 0.00 | 0.00 | 0.00 | — | — |
| Net Common Stock Issuance | 0.45 Cr | 9.30 Cr | 0.00 | — | — |
| Common Stock Issuance | 0.45 Cr | 9.30 Cr | 0.00 | — | — |
| Net Issuance Payments Of Debt | 0.00 | -0.61 Cr | 0.00 | 0.00 | — |
| Net Short Term Debt Issuance | 0.00 | -0.15 Cr | -0.10 Cr | — | — |
| Net Long Term Debt Issuance | 0.00 | -0.46 Cr | 0.00 | 0.00 | — |
| Investing Cash Flow | 0.00 | 0.00 | 15630.00 | 0.00 | — |
| Interest Received Cfi | 0.00 | 0.00 | 630.00 | 0.00 | — |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | — | — |
| Purchase Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | -3.52 Cr | -5.83 Cr | 0.05 Cr | -9904.00 | — |
| Taxes Refund Paid | -0.24 Cr | -0.02 Cr | -0.01 Cr | -7400.00 | — |
| Change In Working Capital | -4.36 Cr | -5.92 Cr | 0.01 Cr | -56902.00 | — |
| Change In Other Current Liabilities | 0.00 | -0.18 Cr | -0.13 Cr | 0.00 | — |
| Change In Other Current Assets | -1.96 Cr | -2.78 Cr | 0.00 | 0.00 | — |
| Change In Payable | 1.55 Cr | -0.21 Cr | 0.32 Cr | 0.04 Cr | — |
| Change In Inventory | 0.00 | 0.00 | 88918.00 | -58362.00 | — |
| Change In Receivables | -4.20 Cr | -2.75 Cr | -0.19 Cr | -0.04 Cr | — |
| Other Non Cash Items | -0.18 Cr | -2803.00 | -630.00 | — | — |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Pension And Employee Benefit Expense | 0.00 | 0.00 | — | — | — |
| Gain Loss On Sale Of Business | 0.00 | 0.00 | 0.00 | — | — |
| Net Income From Continuing Operations | 1.25 Cr | 0.11 Cr | 0.06 Cr | -10.52 Cr | — |
| Repayment Of Debt | — | -0.42 Cr | 0.00 | — | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | — | 1.00 | 1.00 |
| Long Term Debt Payments | — | -0.42 Cr | 0.00 | — | — |
| Net Investment Purchase And Sale | — | 0.00 | 15000.00 | 0.00 | 0.00 |
| Sale Of Investment | — | 0.00 | 15000.00 | 0.00 | 0.00 |
| Purchase Of Investment | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Business Purchase And Sale | — | 0.00 | 0.00 | — | — |
| Sale Of Business | — | 0.00 | 0.00 | — | — |
| Issuance Of Debt | — | — | 0.00 | 0.00 | 0.10 Cr |
| Long Term Debt Issuance | — | — | 0.00 | 0.00 | 0.10 Cr |
| Net Other Investing Changes | — | — | 15000.00 | — | — |
| Cash Dividends Paid | — | — | — | -7000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Gujarat Inject Kerala Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.